Sewell W A C, Khan S, Doré P C
University of Lincoln, and Scunthorpe General Hospital, Scunthorpe and North Lincolnshire DN15 7BH, UK.
Clin Exp Immunol. 2006 Aug;145(2):201-3. doi: 10.1111/j.1365-2249.2006.03126.x.
Early recognition of primary immunodeficiency is essential to reduce morbidity and mortality, and yet failure to recognize these conditions is still a major problem for clinicians around the world. The problem is that general practitioners, physicians and paediatricians lack familiarity with these rare disorders, and lack guidance regarding the appropriate use of immunological investigations. A working party from the European Society for Immunodeficiencies (ESID) has published screening protocols for these rare disorders, which aim to help select which tests should be done in which patients. The success of these proposals will depend on all immunologists disseminating this information in a format that is suitable for the busy generalist, who may not be familiar with these immunological tests and concepts. Laboratories should expect increasing requests for these screening investigations, and should make themselves familiar with these protocols so that appropriate second-line investigations can be arranged in a timely fashion. Speedy and effective communication between the laboratory and clinician is essential, and clinically interpreted reports are mandatory. Although these protocols are part of a screening process, their effectiveness in practice remains to be established, and further refinement will be required over time. The early involvement of the clinical immunologist in cases of suspected immunodeficiency is key.
早期识别原发性免疫缺陷对于降低发病率和死亡率至关重要,然而,未能识别这些病症仍是全球临床医生面临的一个主要问题。问题在于全科医生、内科医生和儿科医生对这些罕见疾病缺乏了解,并且在适当使用免疫学检查方面缺乏指导。欧洲免疫缺陷学会(ESID)的一个工作小组已经发布了针对这些罕见疾病的筛查方案,其目的是帮助选择对哪些患者应进行哪些检查。这些提议能否成功将取决于所有免疫学家以适合忙碌的全科医生的形式传播这些信息,因为他们可能不熟悉这些免疫学检查和概念。实验室应预计对这些筛查检查的需求会不断增加,并应熟悉这些方案,以便能及时安排适当的二线检查。实验室与临床医生之间迅速有效的沟通至关重要,临床解读报告是必需的。尽管这些方案是筛查过程的一部分,但其在实际中的有效性仍有待确定,并且随着时间的推移还需要进一步完善。临床免疫学家在疑似免疫缺陷病例中的早期介入是关键。